Patients, providers and hospitals in Kansas all depend on Medicaid for vital care
Millions of individuals in this country rely on Medicaid. Poor Medicaid: To me Medicaid is like a person who gets beat up on all the time. No one quite understands what to do with Medicaid, or what rules or laws to implement with it.
Hospitals rely heavily on Medicaid payments, and so do nursing homes. Doctors' offices and mental health clinics such as Valeo rely on Medicaid as well. When Medicaid was privatized in Kansas and became known as KanCare, put into three for-profit companies, problems abounded. It became especially problematic for those with developmental and intellectual disabilities.
Now, in the U.S. Congress, there is debate about changes and cuts to Medicaid. It's all very confusing, but the bottom line is all of it would harm the Medicaid program. The people who rely on Medicaid are not criminals. They are not entitled and trying to get something for nothing. These are people who truly can't work and who may need Medicaid for the remainder of their lives.
With Medicaid, people can thrive in their communities and receive lifesaving care and support. Do we care about these folks? Do we care about preserving our hospitals like K.U. Medical Center and the nursing homes where our loved ones reside? Whenever I think of asking tough questions, I always go back to my own faith and ask the question: 'What Would Jesus Do?'
Indeed, now is the time for Congress to ask this question and to search deep within their hearts for the answers to all of these pressing issues.
Valeo Behavioral Health Care has faced budget cuts due to changes and cuts in Medicaid funding. They work with the three managed care companies administering KanCare, and it has been and continues to be a tremendous challenge.
Families know what is best for their children. It's easy to say, 'Let's have cuts and harmful cuts to Medicaid,' when one doesn't have a disabled family member or friend or anyone they know who relies on Medicaid. Disabilities are not the enemy. Poverty shouldn't be the enemy.
I think a lot of people are afraid of the needs of others. They feel overwhelmed and burdened by what they don't understand. Let's imagine if Jesus walked into the U.S. Congress and sat down with all the lawmakers. What would He say to them? Who would He advocate for?
Families are crying out for help and greater funding of Medicaid and not greater burdens. Let's listen to their cries and not turn away. Let's not create burdens for people who are already about to give up.
When I see people in need, I often feel overwhelmed, but I don't ignore that person. Instead, I ask my deep faith what to do. My grandpa, who was a minister for 60 years, used to always end his phone calls with me by saying kindly: 'Rebecca, stay on the road.'
With all the drama and trauma going on these days, I would implore Congressional leaders to not ignore these families with loved ones who need Medicaid. I would encourage them to imagine stepping into my grandpa's summer kitchen — in the back of his old, huge, historic home in Americus, Georgia — and listen to him encourage them to stay on the road, to stick to their values no matter what.
Let's not give up on the right thing to do. Let's reach out during this time and dare to care. It's the only thing to do.
Rebecca Lyn Phillips is a published author, speaker and mental health advocate. Through its opinion section, the Kansas Reflector works to amplify the voices of people who are affected by public policies or excluded from public debate. Find information, including how to submit your own commentary, here.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
31 minutes ago
- New York Post
Beware these 5 signs of a ‘highly invasive' brain cancer — patients typically survive only 15 months
That stinks! A 57-year-old UK father of four recently made headlines when he revealed the bizarre clue that preceded his Stage 4 glioblastoma diagnosis — a 'strange sweet caramel smell.' 'We didn't think much of it,' said Costa Fantis's 27-year-old son, Antonio. 'We definitely didn't know it was a symptom of something so serious.' Before two-time Grammy winner Michael Bolton, 72, was diagnosed with glioblastoma in 2023, he experienced confusion, balance issues, nausea and severe headaches. 5 Michael Bolton performs on stage in 'The Wonderful World of Disney: Magical Holiday Celebration,' which taped in November 2023. He was diagnosed with glioblastoma the following month. ABC via Getty Images The tumor, which occurs when supportive cells in the brain grow and divide uncontrollably, is extremely aggressive and deadly. Most patients survive only 14 to 16 months after diagnosis. 'What makes glioblastoma particularly difficult to treat is its highly invasive nature — it spreads microscopic cancer cells deep into surrounding brain tissue, making it impossible to remove completely with surgery,' Dr. Joseph Georges, a neurosurgeon based in Phoenix, told The Post. Georges shares five early glioblastoma warning signs — and how a specialized cell therapy may prolong patient lives. What are the risk factors for glioblastoma? About 14,500 new glioblastoma cases are diagnosed annually in the US. 5 Dr. Joseph Georges, a neurosurgeon based in Phoenix, reveals five early glioblastoma warning signs — and how a specialized cell therapy may prolong patient lives. The average age of diagnosis is around 64 — the cancer tends to affect adults 45 to 70 years old. Exposure to ionizing radiation as part of radiation therapy for other cancers and certain genetic disorders, such as Turcot syndrome and Lynch syndrome, can increase glioblastoma risk. However, most cases 'occur spontaneously in individuals without risk factors,' said Georges, an assistant professor of neurosurgery at the University of Arizona College of Medicine and Banner University Medical Center-Phoenix. What are the symptoms? Symptoms depend on the tumor's location within the skull. They may include headaches, confusion, seizures, speech difficulty or weakness on one side of the body, Georges said. In Bolton's case, his daughters noticed unusual behavior during a family bowling night in the fall of 2023. 5 This is a scan of a grade 4 glioma brain tumor that's about the size of a tennis ball. Caters News Agency He had bowled out of turn and fallen out of his chair. He was diagnosed a few weeks later. Fantis's tumor appears to have developed in the temporal lobe, which plays a crucial role in processing smells. How is it diagnosed? The tumor can be identified with a CT scan or MRI, and the diagnosis confirmed with a tissue biopsy. 'Several factors influence how long a person might live with glioblastoma,' Georges said, 'including their overall health, neurological function at diagnosis, age and how well they respond to treatments such as surgery, radiation and chemotherapy.' The molecular characteristics of the tumor — like whether it has mutations — can affect the prognosis. How is glioblastoma treated? Metastatic brain tumors — tumors that start elsewhere in the body and spread to the brain — tend to form masses that are better defined than glioblastomas and that can be surgically removed more easily. 'Glioblastoma's diffuse growth pattern, genetic complexity and resistance to standard treatments make it one of the most challenging brain tumors to treat,' Georges noted. 'Complete removal is usually not achievable due to the tumor's infiltrative nature.' 5 Glioblastomas can be identified with a CT scan or MRI, and the diagnosis confirmed with a tissue biopsy. angkhan – Surgery is often followed by radiation therapy to eliminate residual tumor cells and delay progression and chemotherapy to enhance the effectiveness of radiation. Despite this multi-pronged strategy, Georges admitted that 'glioblastoma generally has a poor prognosis due to its aggressive biology and treatment resistance.' How can DOC1021 help? Georges said he has seen better outcomes with an individualized approach. He was the principal investigator of a Phase 1 clinical trial evaluating Dubodencel, also known as DOC1021, which harnesses the power of the patient's special immune cells, called dendritic cells. The cells are exposed to the unique antigens of the tumor outside the body. 'Once trained, the cells are multiplied and then returned to the patient, where they help the immune system launch a targeted attack against the cancer,' Georges said. 'Because this approach uses the patient's own immune cells and doesn't require genetic modification, it offers a highly personalized and comprehensive way to address the complexity and variability of glioblastoma.' 5 These before-and-after brain scans show glioblastoma resolution with DOC1021. The Food and Drug Administration granted fast-track designation to DOC1021, developed by Diakonos Oncology, to treat glioblastoma and pancreatic cancer. Some patients in the DOC1021 Phase 1 trial are approaching 24 to 36 months of survival. 'Early clinical results from the trial showed a 12-month overall survival rate of 88%, markedly higher than the approximately 60% typically seen with standard of care,' Georges said. New Jersey resident Pamela Goldberger, 65, underwent brain surgery, six weeks of chemotherapy and radiation, six weeks of the cell therapy and a year of chemo maintenance as part of the DOC1021 Phase 1 trial. Now, she is back to playing tennis several times a week 2½ years after her diagnosis. 'I'm living my best life right now, and I'm not restricted by not being able to do anything that I would want to do,' she recently told Fox News Digital. The Phase 2 clinical trial is underway — it's expected to be available at 20 US sites.
Fox News
32 minutes ago
- Fox News
What The House Autopen Probe Is Uncovering About The Biden White House
While Congress is on its traditional August recess, the House Oversight Committee is still investigating the alleged cover-up of former President Biden's decline. However, the former President insists he was responsible for all decisions that came out of the White House during his time in office, and former staff members claim they saw no obvious sign of a decline. House Oversight Committee Chairman James Comer (KY-1) joins the Rundown to discuss the Committee's investigation into whether the Biden administration covered up the cognitive deterioration of former President Biden. For decades, advocates have been trying to convince the government that psychedelic drugs could be used as medicine and help with conditions like post-traumatic stress disorder and depression. But their efforts fell short. However, there is hope with the Trump Administration as Health Secretary Robert F. Kennedy Jr. has voiced his openness to testing their effectiveness. A few states have legalized psychedelics for therapy, and Texas has recently approved funding for research into ibogaine, a psychoactive compound found in a West African shrub. Former Texas Governor and first-term Trump Energy Secretary Rick Perry was behind the effort in Texas and hopes it leads to the development of a drug that wins approval for clinical trials and could eventually be given in a monitored hospital setting. Gov. Perry joins the Rundown to discuss the potential benefits of ibogaine and other psychedelic therapies, and how an Afghanistan veteran inspired his advocacy. Plus, commentary by Vice President of Communications for Focus on The Family, Paul Batura. Learn more about your ad choices. Visit
Indianapolis Star
33 minutes ago
- Indianapolis Star
Marion County health leaders praised Braun with $500k in ads. Then the state cut funding
The digital ads flooded the websites of IndyStar and The Indianapolis Business Journal this March and April: "Thank you, Governor Mike Braun," read an all-caps statement next to a portrait of Braun's smiling face, "for fully funding healthcare in Marion County." The $500,000 ad campaign — paid for by the Health and Hospital Corp. of Marion County, the massive public entity that oversees Eskenazi Hospital, the Marion County Public Health Department, Indianapolis Emergency Medical Services and dozens of nursing homes — was specifically thanking the governor for including a $38 million annual state payment for uninsured and low-income patients at Eskenazi Hospital in his proposed state budget, an HHC spokesman said. The state has paid that amount to HHC annually since 2009 in recognition of Eskenazi's role as a safety net for those who can't pay. But that praise proved premature. In April Senate Republicans released their own version of the budget that cut the $38 million in support. Weeks later, lawmakers removed an additional $17 million from the local health department while adjusting for a weaker revenue forecast. Braun signed the new two-year budget into law this May, quietly approving the cuts. Those two losses now account for nearly half of a $125 million reduction in revenues that HHC is forecasting for 2026. To counter the funding shortfall, hospital department heads are being urged to trim their costs and HHC leaders are searching for new funding options — all while vowing to continue providing care for Marion County's most vulnerable residents. "Every division of Health & Hospital Corporation will be expected to serve more with less," HHC spokesman Curt Brantingham told IndyStar in a written statement. State Sen. Ryan Mishler, the Senate's chief budget writer, did not respond to a question through his spokesperson about the reasoning for the $38 million cut in state aid for patients who struggle to afford health care. Along with that money, the HHC also lost nearly $17 million in annual state dollars through Health First Indiana, an investment in local health departments passed under Gov. Eric Holcomb that aimed to combat years of subpar public health funding. That cut came after lawmakers learned in April that they would have $2 billion less to spend because of a projected revenue decline spurred by national economic uncertainty. The bygone state revenues and rising costs, due in large part to inflation and economic instability, have contributed to HHC's operating deficit of nearly $100 million for next year, interim CFO James Simpson said during a July 29 board meeting. The HHC's proposed budget for 2026 is more than $2.6 billion — about $1 billion larger than the city of Indianapolis' most recent annual budget. Overall, the HHC is funded by a mix of sources: patient revenue from Eskenazi Health and nursing homes, local property and income taxes, government grants and federal programs like Medicaid. Brantingham said the $500,000 ad campaign thanking Braun was paid for from HHC's general fund and did not require approval from the HHC Board of Trustees — the seven-member board including three members appointed by the Indianapolis mayor, two by the City-County Council and two by the county commissioners. Asked why the ad campaign was approved before the final state budget had passed, Brantingham said HHC "was advocating for the governor's annual $38 million line item" to be included. For 2026, HHC plans to send $25 million in property taxes to Eskenazi to replace some of the lost state funding. Simpson said he expects the agency can reduce the $100 million deficit in the coming years by dipping into more than $800 million in cash reserves in a general fund, if needed, and maximizing the county property tax revenue it can collect. That wouldn't necessarily increase the amount of property taxes Marion County residents pay, because of property tax caps, but it will mean less money for other county taxing units like Indianapolis. To close Eskenazi Health's nearly $60 million portion of HHC's total deficit, CEO Lisa Harris said she's asking her department leaders to find ways to reduce costs by 3.5% moving forward. "Leaders of every division are focused on finding efficiencies and systemwide improvements that help HHC continue to serve our community and our state with care and compassion," Brantingham said in a statement. The HHC's funding woes come as Indiana health providers expect to lose billions in federal Medicaid dollars over the next decade after the passage of the federal "One Big Beautiful Bill Act." The reductions could cost Indiana an estimated $31 billion over the next decade, according to an analysis by the Urban Institute and Robert Wood Johnson Foundation, with the state's hospitals losing nearly $13 billion. The HHC expects to make up some of that difference through a new "State-Directed Payments" program that will supplement Indiana's low Medicaid reimbursement rate, leaders say. Meanwhile, tens of thousands of Hoosiers are among the millions of Americans who could lose Medicaid coverage. Health experts predict a growing number of them will turn to emergency rooms for treatment that tends to be more expensive. Harris at Eskenazi Health said she's concerned about the long-term consequences of the Medicaid cuts, which could result in longer wait times in emergency departments and more suffering from late-stage diseases that could have been treated sooner. "When people avoid primary care, preventive care, we expect that more will end up in the emergency department," Harris said at the HHC meeting. "They will flood the emergency department, making access a challenge for everybody seeking emergency care ... And then our costs, the overall costs to the system and the community for caring for disease, will go up."
